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as well as the mean dose or specific critical doses of 10 
organs at risk (OARs). 
Pareto fronts are well suited for plan comparison as a Pareto 
optimal solution is obtained when one objective cannot be 
improved without deteriorating another [3]. In this study 
Pareto fronts are created by varying one parameter (pitch or 
MF), while anchoring the others. 
Results: For small pitches (0.10-0.20), MF does only influence 
plan quality. For these conditions treatment time is 
invariable because gantry period already reached its minimal 
value of 12sec. Increasing the pitch (≥ 0.25) will in general 
reduce treatment time and for these larger pitches, lowering 
MF will additionally lower treatment time but also PTV 
coverage and OAR sparing will vary. 
The Pareto fronts in figure 1 cover a wide range of Pareto 
optimal combinations: from pitch 0.10 and MF 3.0 to pitch 
0.50 and MF 1.2. Despite the Pareto optimality of these 
points, not all of them result in clinical acceptable plans. The 
combination of a large pitch (0.50) and a low MF results in a 
fast treatment of 1m56 at the price of unacceptable doses to 
OARs. On the other site of the Pareto front, small pitches 
(0.10-0.20) introduce too much overlap between adjacent fan 
beams. Due to this excess of modulation possibilities and 
although OARs can be maximally spared, this will result in an 
unnecessary long treatment time of 8m58. 
MF and pitch both have an impact on plan quality/treatment 
time and consequently it is a planner responsibility to choose 
the patient specific, preferable combination. 
Conclusions: This Pareto front study shows that with 
TomoEdge for a FW of 5cm clinical acceptable Pareto optimal 
combinations exist if pitch and MF are chosen in a range of 
[0.30-0.45] and [2.0-3.0] respectively. These values generate 
plans with on one hand a minimised dose to the OARs and on 
the other hand minimised HI and CI for the PTVs. The 
corresponding treatment time varies from 2m36 to 3m50s. 
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Purpose/Objective: Dose-volume (Dvh hereafter) plan 
evaluation and inverse optimization is an accepted standard 
of care in external beam radiotherapy. Recently, inverse 
optimization based on energy minimization (Energy 
hereafter) was suggested as a possible alternative. The 
purpose of this work is to apply Dvh and Energy based inverse 
optimization in NSCLC, and to compare the performance of 
each approach. 
Materials and Methods: Fourteen lung patient plans were 
retrospectively optimized for IMRT. For each subject, the 
target had an estimated range of motion of less than 0.5 cm, 
and therefore no motion management was considered. The 
optimization was performed with Dvh and Energy based 
objective functions. Those different objectives were used 
only for the organs at risk (OARs). For the planning target 
volumes (PTVs) minimum, maximum, and uniform dose 
objectives were used with either optimization. In each 
optimization the CT dataset corresponding to mid-ventilation 
was used. With either optimization nine equally spaced 
beams were used. Step-and-shoot IMRT with total of 72 
segments was used in each plan. The minimum allowed 
segment area and minimum monitor units (MUs) per segment 
were set the same for both optimization approaches. Dvh and 
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Energy plans were normalized such that 95% of the PTV 
received the prescription dose. Once prescription was 
achieved, the doses to OARs, such as spinal cord, heart, 
esophagus, and healthy lungs were iteratively lowered until 
standard deviation of the dose across the PTV in each plan 
became less than 4%. Dose indices (DIs), such as DPTV95% (dose 
to 95% of the PTV), DCord1%, Desophagus50%, Dheart33%, Dlungs20%, 
Dlungs30%, and volume indices (VIs) such as Vlungs2000 cGy, and 
Vlungs3000 cGy were compared. The dosimetric differences among 
the DIs and the VIs were subjected to a two-tailed paired t-
test to determine the statistically significant dose differences 
(p < 0.05). 
Results: The table below summarizes statistically significant 
differences over all indices. Negative differences indicate 
lower doses/masses/integral doses with Energy optimization. 
On average the DIs and the VIs resulting from the Energy 
optimization are lower than the indices obtained with Dvh 
optimization. With very few exceptions this is true for each 
individual DI and VI. Notably, the total energy deposited in 
the entire volume outside of the target was on average lower 
for Energy optimization with statistically significant 
difference of 14.4%. The same was true for each patient, i.e. 
the integral dose outside of the PTV was always lower with 
energy optimization. 
Conclusions: It was found that in inverse planning Energy 
based optimization results in lower doses to nearby OARs. For 
identical target coverage Energy based plans resulted in 
statistically significant OAR sparing ranging from 18% to more 
than 80%.  
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Purpose/Objective: The aim of VoxTox is to establish 
delivered dose over a course of radiotherapy and its 
relationship with toxicity, in 1920 participants treated with 
Intensity Modulated IGRT for head and neck cancer, prostate 
cancer, or a central nervous system tumour. As part of the 
VoxTox project, we required a system for automatic 
recalculation of dose cubes, using the MV CT images acquired 
for IGRT on a TomoTherapy machine.  
Materials and Methods: We have developed a system that 
can be integrated within the GANGA computational-task 
management system originally developed for use on the 
ATLAS and LHCb experiments at CERN. We are extracting 
images, RTPLAN objects and daily set-up information from 
the TomoTherapy archive. Software has been developed in 
MatLab to calculate the delivered dose by applying the 
RTPLAN to the MV images (supplemented by the planning 
kVCT images where the MV dataset does not extend far 
enough). We have acquired data on the variation over 7 years 
of the HU calibration of the MV images. We combine the 
doses with rectal outlines determined from the MV images of 
prostate radiotherapy patients to produce dose surface maps 
(DSM).  
Results: To calculate dose on 128x128x22 calculation points, 
took 40.5 minutes in MatLab 2013b on an Intel Xeon 3.3 GHz 
with 8GB of RAM, using Windows 7. From 2007 to 2011 there 
was considerable variation in HU calibration within +/-30HU. 
Following the introduction of the dose-rate servo in 2011, 
and a new weekly calibration procedure in 2012, this is stable 
to better than +/-10HU. .  
The figure shows a typical rectal DSM summed over 37 
fractions; vertical axis is sup-inf, horizontal axis normalised 
circumference of rectum. The MV images did not extend the 
full length of the rectum, so this part has been determined 
from the planning kV CT. The join is feathered as a result of 
the fact that the superior and inferior margin of the MV 
images varies from day to day. 
For some patients the DSMs are similar to DSMs calculated 
from the original treatment plan, in some they show larger 
areas of high dose, in some they show smaller areas. 
 
 
Conclusions: We have developed a system for automatic dose 
recalculation of Tomotherapy dose distributions. This does 
not tie up the clinically-needed planning system, but can be 
run on a cluster of independent machines. Using the 
computational-task management system GANGA enables 
automation of the process. In conjunction with the ongoing 
collection of patient toxicities, this method of automatic 
recalculation will enable us to achieve the goals of VoxTox  
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Purpose/Objective: It is widely assumed that Monte Carlo 
(MC) methods produce the most accurate results in dose 
calculations problems but, due to their high computational 
cost, they are rarely used in routine radiotherapy (RT) 
treatment calculations. In this work a cloud-based solution 
for MC verification of RT treatments is presented.  
